Wnt signaling has been implicated in somite, limb, and branchial arch myogenesis but the mechanisms and roles are not clear. We now show that Wnt signaling via Lef1 acts to regulate the number of premyogenic cells in somites but does not regulate myogenic initiation in the limb bud or maintenance in the first or second branchial arch. We have also analysed the function and regulation of a putative downstream transcriptional target of canonical Wnt signaling, Pitx2. We show that loss-of-function of Pitx2 decreases the number of myogenic cells in the somite, whereas overexpression increases myocyte number particularly in the epaxial region of the myotome. Increased numbers of mitotic cells were observed following overexpression of Pitx2 or an activated form of Lef1, suggesting an effect on cell proliferation. In addition, we show that Pitx2 expression is regulated by canonical Wnt signaling in the epaxial somite and second branchial arch, but not in the limb or the first branchial arch. These results suggest that Wnt/Lef1 signaling regulates epaxial myogenesis via Pitx2 but that this link is uncoupled in other regions of the body, emphasizing the unique molecular networks that control the development of various muscles in vertebrates.
Introduction
During vertebrate embryogenesis, the striated musculature of the head and trunk arises from two distinct regions: the somitic mesoderm gives rise to the axial, appendicular, and tongue musculature whilst the unsegmented paraxial mesoderm, together with the prechordal plate, forms the majority of the craniofacial musculature. These distinct origins are also reflected by different molecular signatures, for example, the axial skeletal musculature expresses the transcription factor Pax3, which is essential for myogenesis, but the developing craniofacial musculature does not Bothe and Dietrich, 2006; Brunelli et al., 2007; Buckingham and Relaix, 2007) reviewed in Noden and Francis-West (2006) . Despite these differences, commitment to the myogenic pathway in all regions of the body is controlled by myogenic regulatory factors (MRFs) Myf5, MyoD, Mrf4, and myogenin (Rudnicki et al., 1993; Tajbakhsh et al., 1996) . This is followed by terminal differentiation characterised by the expression of myosin heavy chains (MyHC) .
In response to extrinsic patterning signals, each somite divides into two main compartments: a dorso-lateral epithelial compartment called the dermomyotome and a ventral mesenchymal compartment called the sclerotome, the progenitor of the vertebrae and ribs. The dermomyotome is a transient structure, which contributes cells to the epaxial and hypaxial myotome in successive phases. The primary myotome is generated by cells that enter first from the medial dermomyotome border, in a second phase myocytes are produced from all four dermomyotome edges. Finally, the central portion of the dermomyotome undergoes an epithelial-to-mesenchymal transition (EMT) leading to an influx of muscle progenitor cells into the primary myotome (Gros et al., 2004; Manceau et al., 2008) . Recent work has shown that the expansion of the latter population of myogenic progenitors is influenced by notch and myostatin signaling, which affects their terminal differentiation (Manceau et al., 2008; SchusterGossler et al., 2007; Vasyutina et al., 2007) . The limb and tongue musculature arises by delamination of the hypaxial dermomyotome in response to hepatocyte growth factor signaling and myogenic cells migrate to their final destination (Dietrich, 1999) . Within the developing limb bud, they become committed to the myogenic lineage and form the dorsal and ventral muscle masses.
The Wnt family of growth factors play key roles during embryonic myogenesis. Early studies demonstrated that a combination of Shh protein and Wnt1 or Wnt3a-expressing fibroblasts is sufficient to activate skeletal muscle-specific gene expression in explants of somites or presegmented mesoderm (Münsterberg et al., 1995) . Wnt signaling has also subsequently been implicated in myogenic commitment within the developing limb bud; however, it has been shown to be inhibitory for craniofacial myogenesis (Anakwe et al., 2003; Geetha-Loganathan et al., 2005; Tzahor et al., 2003) . The Wnt ligands can signal through a number of pathways including the β-catenin-dependent pathway, planar cell polarity and calcium pathways (reviewed by Gordon and Nusse, 2006) . The best characterised is the pathway involving β-catenin, the glycogen-synthase kinase 3β (GSK3β) destruction complex and the T-cell factor/lymphoid enhancing factor-1 (Tcf/Lef1) transcription factors. In an uninduced cell, β-catenin is phosphorylated and removed by the GSK3β destruction complex and Tcf/Lef1, together with Groucho, acts as a transcriptional repressor. However, Wnt binding to the serpentine frizzled receptor results in the inhibition of the GSK-3β destruction complex allowing the accumulation of β-catenin, which is subsequently translocated to the nucleus. Here, β-catenin binding converts Tcf/Lef1 to a transcriptional activator (reviewed by Stadeli et al., 2006; Willert and Jones, 2006) . Canonical Wnt signaling also requires a co-receptor, the low-density lipoprotein receptor-related proteins 5 and 6 (LRP5/6) (Niehrs, 2006) . Wnt signaling is modulated by a number of antagonists including extracellular antagonists such as the secreted frizzled related proteins/frizbees (Sfrps/Frzb) and Dkk1. The Sfrps have homology to the extracellular domain of the frizzled receptors and bind to Wnt proteins preventing their binding to the frizzled receptors. The Sfrps are, therefore, not specific to a particular Wnt pathway. In contrast, Dkk1 acts by binding directly to the extracellular domain of LRP-5/6 and therefore interferes specifically with canonical Wnt signaling.
The canonical Wnt signaling pathway is essential for the development of the epaxial musculature, consistent with the expression of β-catenin and Lef1 in the dorso-medial lip of the dermomyotome (Schmidt et al., 2004; Schmidt et al., 2000) . The importance of Wnt signaling for the activation of myogenesis is further illustrated by the finding that transplacental delivery of Frzb1 inhibits somite myogenesis. This study suggested that Wnt signals may act by regulating both myogenic commitment and expansion of committed cells (Borello et al., 1999) . In addition, the detailed analyses of Myf5 regulatory elements revealed important Tcf/Lef sequences, which mediate the correct spatiotemporal expression of Myf5 in the epaxial domain of the somite (Borello et al., 2006; Teboul et al., 2002) . Consistent with this, experiments using targeted electroporation of activated β-catenin showed that Wnt/β-catenin signaling is crucial for myogenic specification (Gros et al., 2009) .
The transcription factor, Pitx2, is a target of the β-catenin-dependent Wnt pathway (Kioussi et al., 2002) . Pitx2 can also be an effector of this pathway, for example, in epithelial cells it forms a functional complex with β-catenin and Lef1 to synergistically induce transcription from the Lef1 promoter Vadlamudi et al., 2005) , thus establishing a positive feedback loop. It is known that Pitx2, Pitx1, and Pitx3, are expressed in the developing musculature (Dong et al., 2006; Golding et al., 2004; Poulin et al., 2000; Shih et al., 2007a,b) . Pitx2 has been shown to regulate proliferation in cardiac neural crest cells, the pituitary gland, and the myogenic cell lines, C2C12 and Sol8 (Kioussi et al., 2002; Martinez-Fernandez et al., 2006) . In the first branchial arch, Pitx2 overexpression increases the number of differentiating myocytes. Pitx2 also regulates cell survival, as gene inactivation in mice results in the apoptosis of first branchial arch myogenic cells (Dong et al., 2006; Shih et al., 2007a) .
Here, we examined the relationship between Lef1 and Pitx2 and show that Pitx2 expression is regulated by Wnt/Lef1 signaling in the myotome and second branchial arch. In addition, we investigated the function of Lef1 and Pitx2 during somite and limb myogenesis.
Materials and methods

Embryo manipulations, RCAS infection, electroporation, and bead implants
Fertile white Leghorn chicken eggs were obtained from Henry Stuart (Lincolnshire) and incubated at 37.5°C and were staged according to Hamburger and Hamilton (HH) (Hamburger and Hamilton, 1992) . Stage 12 embryos were used for retrovirus (RCAS) infection and embryos at HH16 were used for somite electroporations.
After manipulations, eggs were sealed and incubated for 24 or 48 hours, depending on the experiment. Embryos were harvested in DEPC PBS, fixed overnight in 4% paraformaldehyde at 4°C, and processed for in situ hybridisation. The timing of somite infections should predominantly affect the primary myotome.
Concentrated retrovirus was prepared following standard protocols (Morgan and Fekete, 1996) . The following RCAS constructs were used: RCAS-ΔNLef1, RCAS-ΔNLef1-VP16, RCAS-ΔN34Lef1, RCASPitx2a, RCAS-Pitx2a-En, and RCAS-GFP. Pitx2 viruses were kindly provided by Yi-Ping Chen (Tulane University, New Orleans; Yu et al., 2001 ). Concentrated RCAS virus was injected into presegmented mesoderm of HH stage 12 embryos and the embryos were allowed to develop for 48 hours before harvesting. The contralateral, uninfected side, and/or RCAS-GFP-infected somites served as control. The spread of infection was examined using in situ detection of viral gag mRNA. Alternatively, pellets of O-line cells infected with the retroviruses were grafted into the developing limb bud at stages 17/18 and embryos were allowed to develop until day 8 (Anakwe et al., 2003) .
Electroporation was carried out as described in Sweetman et al. (2008) . Briefly, HH16 epithelial somites 2-6 were injected with plasmid DNA at a concentration of 1.5 mg/ml. Positive and negative platinum electrodes were kept 2 mm apart and placed on either side of the somites. A TSS20 Ovodyne electroporator (Intracel) was used to apply 5 pulses of 15 V for 15 ms. PBS buffer was added before and after electroporation.
For the Dkk1 manipulation studies, affigel beads were soaked in 500 ng/μl solution of recombinant mouse Dkk1 protein (carrier-free, R&D Systems) for 1 hour at 37°C. They were applied to either the first or the second branchial arches or the developing limb buds at HH stages 20/21 of embryonic development. Control beads were soaked in 0.1% BSA in PBS. The embryos were allowed to develop for 24 hours and were then analysed for changes in gene expression by wholemount in situ hybridisation.
Micromass cultures
Micromass cultures from HH stage 19/20 chick wing buds were prepared as described (Anakwe et al., 2003) . Briefly, the ectoderm was dissociated from the limb mesenchyme in 2% trypsin and the mesenchymal cells were disaggregated to a single-cell suspension. A total of 2 × 10 5 cells were resuspended in 10 μl of concentrated RCAS retrovirus and plated as a droplet. After 1 hour, the micromass cultures were flooded with DMEM containing 10% FCS, 1% chick serum, 1% penicillin/streptomycin. Micromasses were cultured for 3 days, fixed in methanol for 1 minute at room temperature and analysed for Pan-MyHC expression using the A4.1025 antibody (DSHB). Each assay consisted of at least 3 micromasses and the experiments were performed in triplicate. Statistical significance was determined using the Student's t-test.
In situ hybridisation and immunohistochemistry Whole-mount in situ hybridisations were carried out as previously described (Anakwe et al., 2003; Schmidt et al., 2000) . Anti-sense Lef1, Pitx2, MyoD, Myf5, Mgn, MyoR, Pax3, Pax7, and anti-gag probes were used (Dastjerdi et al., 2007; Smith et al., 2005; Yu et al., 2001) . After in situ hybridisation, embryos were fixed in 4% PFA, washed with PBS, and transferred into gelatin for vibratome sectioning or into 30% sucrose/PBS and finally OCT for cryosectioning and immunoanalysis. Ten-micrometer sections were subjected to a double immunostaining using phospho-histone H3 and MF-20 antibodies (DSHB, 1:500). Briefly, sections were incubated with 0.1% Triton and treated with 1:10 H 2 O 2 / PBS for 10 minutes. After washing twice in PBS, sections were blocked in 10% goat serum and primary antibody was applied overnight at 4°C. Sections were blocked in 10% goat serum before applying secondary antibodies, anti-rabbit Alexa Fluor 488 to detect phospho-histone H3 (green) (Molecular Probes), at 1:1000. Sections were treated with DAPI to stain nuclei and mounted in Mowiol. Pictures were taken on an Axioscope microscope using Axiovision software (Zeiss, Germany).
Statistical analyses
The number of phospho-histone H3-positive cells was counted in the dermomyotomes and myotomes of RCAS-ΔNLef1-VP16-or RCASPitx2a-infected and contralateral, non-infected somites. SPSS was used to calculate means and standard errors. Counts from infected and non-infected sides were treated as paired readings (Lef1, n = 137, Pitx2, n = 47) and statistical analysis was carried out to confirm the significance of the observed differences (Wilcoxon test).
Results
Canonical Wnt signaling via Lef1 affects the size of the myotome
Wnt signaling via β-catenin promotes myogenesis. In order to elucidate its role in more detail we infected presegmented mesoderm at HH12 with RCAS retrovirus expressing a mutant form of Lef1, RCASΔNLef1, which retains the HMG box that binds to DNA, but lacks the β-catenin co-activator and Groucho co-repressor binding domains (Fig. 1G ). One side of the embryo was targeted allowing the contralateral side to be used as control. After 48 hours, successful transfection and targeting was determined by in situ detection of viral gag transcripts (Figs. 1A and A′). Effects of ΔNLef1 on myogenic differentiation were investigated by in situ hybridisation analyses of a series of marker genes. This showed that transfected somites had a thickened myotome characterised by an increased number of cells expressing Pax-7, a premyogenic marker gene (n =12; Figs. 1B and B′). In addition, expression of the myogenic bHLH transcription factors, MyoD (n = 17) and myogenin (n = 7) was increased on the transfected side (Figs. 1A, A′, C, and C′). As the ΔN-Lef1 amino-terminal deletion protein cannot interact with the Groucho co-repressor, these results are consistent with the idea that loss of Lef1-mediated repression was sufficient to activate myogenesis. Furthermore, the increased number of cells expressing Pax-7 and Pax-3 suggests that Wnt signaling via Lef1 acts early during myogenic specification.
To extend these observations, we used the same deletion construct fused to the strong transcriptional activator VP16 (Fig. 1G ). ΔNLef1-VP16 was targeted to the developing somite by RCAS-mediated infection (Figs. 1D-F). Alternatively, newly formed epithelial somites were electroporated with an expression vector, pCAβ encoding the same protein: ΔNLef1-VP16. The pCAβ vector also expresses GFP from an IRES (Supplemental Figs. 1A-D). After 24 hours, in situ detection of ectopic GFP expression determined successful targeting (Supplemental Figs. 1A and A′). The phenotype observed with ΔNLef1-VP16 was similar to that observed with ΔNLef1. Sections through the transfected region showed that ΔNLef1-VP16 resulted in increased expression of premyogenic markers Pax-3 (n = 6; Figs. 1D and D′), Pax7 (n = 3; data not shown) and myogenic markers MyoD (n = 9; Figs. 1E and E′) and Mgn (n = 8; Figs. 1F and F′). The same results were obtained after electroporation of pCAβ-ΔNLef1-VP16 (Supplemental Figs. 1A-D) ; however, phenotypes after RCAS-mediated overexpression were usually stronger than after electroporation.
Next, we examined the effects of loss of Lef1-mediated transcriptional activation on myogenesis by targeted misexpression of RCAS-ΔN34-Lef1. In this deletion, the β-catenin binding domain was specifically removed, whilst the binding domain for the Groucho corepressor was retained, leading to a dominant negative effect (Fig.  1G) . Expression of RCAS-ΔN34-Lef1 in presegmented mesoderm resulted in a marked decrease of MyoD (n = 11; Figs. 1H and H′), Mgn (n = 10; Figs. 1I and I′), and Myf5 (n = 11; Figs. 1J and J′) in somites on the infected side of the embryo.
Lef1 interacts with Pitx2 to regulate myogenic differentiation in somites
Pitx2 is a direct transcriptional target of the Wnt-β-catenin signaling; in addition, it acts with Lef1 to regulate the Lef1 promoter, creating a positive feedback loop (Ai et al., 2007; Amen et al., 2007; Vadlamudi et al., 2005) . In the mouse embryo, Pitx2 is expressed in the developing myotome, branchial arch mesoderm, and limb myogenic cells (Kioussi et al., 2002; L'Honore et al., 2007; Marcil et al., 2003; Shih et al., 2007b) . Expression of Pitx2 in chick embryonic musculature has, to date, only been reported in the branchial arches (Dong et al., 2006) . Therefore, to investigate a potential interaction of Pitx2 with Lef1 during somite myogenesis, we analysed Pitx2 expression in chick somites.
Pitx2 transcripts were first detected in the hypaxial myotome of HH20 embryos ( Fig. 2A) . By HH22, Pitx2 was expressed in committed myogenic cells throughout the myotome, but with lower levels in the central region (Figs. 2B and B′) . In posterior somites, expression was still limited to the hypaxial domain (Fig. 2B) . Expression of Pitx2 is overlapping with MRFs, Lef1, Tcf1, and β-catenin (Schmidt et al., 2004) , and to investigate the relationship between canonical Wnt signaling and Pitx2 during embryonic myogenesis, we examined the effects of RCAS-ΔNLef1-VP16 and RCAS-ΔN34Lef1 on Pitx2 expression in developing somites (Figs. 2C-D′) . Targeted misexpression of ΔNLef1-VP16 by RCAS infection of epithelial somites at HH17 led to an increase in Pitx2 transcripts, particularly in the epaxial myotome (n = 16) (Figs. 2C and C′) . In contrast, infection with a retrovirus encoding ΔN34Lef1 caused reduced Pitx2 expression (n = 7) (Figs. 2D and D′). The negative effect of ΔN34Lef1 on Pitx2 expression was seen in epaxial and central myotomes, but not in the hypaxial domain.
To examine whether Lef1 may affect the myotome via Pitx2, at least in part, we determined the phenotypes resulting from RCAS-mediated expression of either a Pitx2a full-length protein or Pitx2a-En where the engrailed repressor is fused to Pitx2a (Figs. 2E-H) . Targeted expression of Pitx2a resulted in a dramatic increase in myotome thickness as indicated by expression of MyoD (n =14) and Mgn (n=13) (Figs. 2E-F′) . The phenotype was most apparent in, but not limited to, the epaxial myotome. Conversely, RCAS-Pitx2a-En resulted in a loss of transcripts for the myogenic markers Myf5 (n= 12, not shown), MyoD (n =20), and Mgn (n =4), throughout myotomes (Figs. 2G-H′) .
Lef-1 and Pitx-2 expression increased cell proliferation in dermomyotomes and myotomes
Next we investigated the potential mechanism by which Lef1 and Pitx2a affect the size of the myotome. In particular, we determined whether proliferation of myogenic cells could be affected in developing somites, as has been demonstrated previously for Pitx2a in cardiac neural crest cells and the myogenic satellite C2C12 and Sol8 cell lines (Kioussi et al., 2002; Martinez-Fernandez et al., 2006) . Labelling with phospho-histone-H3 was used to quantify the number of mitotic cells 48 hours after transfection with RCAS-ΔN-Lef1 (Fig.  3A) or RCAS-Pitx2a (Fig. 3C) . The position of the myotome was identified in brightfield images and the number of mitotic cells within infected dermomyotomes and myotomes was counted and compared with the number of mitotic cells in non-infected contralateral somites (Figs. 3B and D) . After infection with RCAS-ΔNLef1 or RCAS-Pitx2a more cells in mitosis were detected (30%), suggesting that proliferation may be increased (Fig. 3 compare panels A and B with C and D; Fig. 3E , P b 0.01). This conclusion is supported by the overall increase in myotome size. The statistical significance of the observed differences was confirmed using the SPSS Wilcoxon test (number of sections counted/paired counting: ΔNLef1, n = 137; Pitx2, n = 47).
The molecular regulation of limb and branchial arch myogenesis differs from somite myogenesis
In the limb bud, the temporal and spatial expression pattern of Pitx2 is consistent with that previously reported in the mouse (Kioussi et al., 2002; L'Honore et al., 2007; Marcil et al., 2003; Shih et al., 2007b ) (Supplemental Fig. 2 ). Pitx2 transcripts were first observed at stage 21. Comparison of MyoD versus Pitx2 expression on adjacent sections through limb buds showed that the Pitx2 expression domain encompasses both that of MyoD and Pax3 (Supplemental Figs. 2D and E). This indicates that Pitx2 is expressed in developing myogenic cells both prior to and after myogenic commitment (Supplemental Figs. 2A, B, D , and E). This is in contrast to the somite where Pitx2 is expressed after myogenic commitment.
The previous experiments showed that Lef1/Pitx2 regulates myogenesis within the somite and we provided evidence that proliferation of myogenic progenitors is affected. As myogenesis is differentially controlled in different regions of the body, we extended our analysis to the developing limbs and branchial arches (Fig. 4) . First, we analysed possible effects of canonical Wnt signaling on Pitx2 expression. Application of beads soaked in Dkk1, an antagonist that specifically blocks this pathway, did not alter Pitx2 expression in the limb bud (Fig. 4A, n = 6 ). Likewise, infection of the limb buds with RCAS retrovirus expressing dominant negative ΔN34-Lef1 had no effect on Pitx2 expression (n = 5, Figs. 2O and P). However, RCASΔNLef1 infection of limb buds led to a slight increase in Pitx2 transcripts (Figs. 4M and N; n = 3). These findings suggest that Wnt signaling can positively affect Pitx2 expression in the limb bud mesenchyme; however, it is not required.
To further investigate the relationship between Pitx2 and limb myogenesis together with the role of the canonical Wnt pathway during limb myogenic differentiation, we analysed the expression of the myogenic markers, Myf5, MyoD, and Mgn following activation or inhibition of Wnt signaling by misexpression of ΔNLef1 or ΔN34Lef1 proteins (Figs. 4E-H; n = 4, n = 7). Alternatively we applied Dkk1 beads (Figs. 4B and C) . These studies demonstrated that myogenic commitment within the limb bud is not regulated by the canonical Wnt pathway (Dkk1: Myf5, n = 5; MyoD, n = 5), a conclusion consistent with recent studies in the mouse (Hutcheson et al., 2009) .
To determine whether Pitx2, which in limb bud mesenchyme seemed to be Wnt-independent, could affect myogenesis, we used RCAS to misexpress Pitx2a (Figs. 4I and J; n = 30) or Pitx2a-En (Figs. 4K and L; n = 16). Embryos were harvested 48 hours after infection. At this time, we could not detect any differences in expression of MyoD and Mgn transcripts between infected and non-infected limb buds, suggesting that limb bud myogenesis was independent of Pitx2a, at least in the early phase.
We also extended these studies to the branchial arches, where myogenic differentiation is differentially regulated. In the head, application of Dkk1 soaked beads inhibited Pitx2 expression in the second, but not in the first, branchial arch mesoderm and ectoderm (Figs. 4W and X), indicating that canonical Wnt signaling may be involved. This was consistent with analysis of the TOPGAL reporter mouse at E9.5, which showed LacZ reporter activity, indicative of canonical Wnt signaling, within the mesoderm of the second but not the first branchial arch (Figs. 4Y and Y′) . However, as in the limb bud, application of Dkk1 beads did not alter the expression of myogenic markers (Figs. 4Q-V; ba1: Myf5, n = 7; MyoD, n = 8; MyoR, n = 1; ba 2: Myf5, n = 2; MyoD, n = 3; MyoR, n = 3).
Late myogenic differentiation in the limb is affected by Pitx2
Although we did not detect an effect of Pitx2 on early limb myogenesis, we have previously shown that Pitx2 determines the number of terminally differentiated myocytes in the first branchial arch (Dong et al., 2006) . Therefore, we next investigated a potential role of Pitx2 during terminal myogenic differentiation in the limb bud. RCAS(BP) retroviruses encoding either Pitx2a-En or Pitx2a proteins were used to infect developing limb cells in micromass cultures, a simple assay which allows quantification of myocyte differentiation (Figs. 5G and H) . Limb bud cells were isolated from HH19/20 embryos and plated at a high density in the presence of high-titer RCAS retrovirus. Terminal myogenic differentiation was determined after 3 days by staining with the pan-MyHC antibody. The effect of both isoforms of Pitx2, Pitx2a and Pitx2c, was examined, as it has been shown that these can have differential effects (Yu et al., 2001 ). In the micromass assay, misexpression of Pitx2a or Pitx2c significantly increased the number of differentiated myocytes compared to RCAS-GFP-infected controls. In contrast, blocking Pitx2a or Pitx2c function had the converse effect and reduced myocyte number significantly (Figs. 5G and H; P b 0.05).
We extended this in vitro analysis to in vivo studies. Here we grafted pellets of RCAS-infected cells into a HH18/19 limb bud. This results in viral spread throughout the majority of the limb (Duprez et al., 1996) . RCAS-infected embryos were incubated until day 8 of development when primary myogenesis is complete. The limbs were fixed and immunostained with the pan-MyHC antibody to analyse terminal differentiation. Muscle development was compared to the uninfected contralateral limb. The number of myofibers was counted every 40 μm through the zeugopod of the limb and the flexor and extensor muscles were analysed separately. We found that blocking Pitx2a function in vivo by expressing Pitx2a-En virus reduced the number of differentiated myocytes/myofibers (Figs. 5C and D; n = 4 limbs; average number in control extensor muscles, n = 159 versus 77 in infected extensor muscles, P b 0.01; average number control flexor muscles, n = 280 versus 234 in infected flexor muscles, P b 0.01). Conversely, overexpression of Pitx2a significantly increased the number of differentiated myocytes/myofibers and hence increased muscle size (Figs. 5E and F; flexor muscles: control n = 265 versus 339 in the infected side, P b 0.05; extensor muscles, control, n = 158 versus 219 in infected limbs, P b 0.01). Infection with the control GFP virus did not significantly alter the number of myofibers or patterning of the muscles (extensors, control, n = 162 versus GFP-infected, n = 158, Figs. 5A and B) . This demonstrated that within the limb bud, Pitx2 affected the number of myocytes/myofibers and thus final muscle size.
Discussion
The canonical Wnt signaling pathway has been implicated in epaxial, limb and branchial arch myogenesis: in the epaxial somite and limb bud Wnt signaling has been proposed to be involved in myogenic commitment whereas in the head, it has been shown to be inhibitory (reviewed by Noden and Francis-West, 2006) . Here, we have uncovered differential requirements and functions of Wnt/Pitx2 in these regions and identified the stages in the myogenic pathway when canonical signaling acts. By targeted misexpression of the ΔNLef1 mutant construct, we uncover that de-repression of canonical Wnt signaling is sufficient to promote myogenesis in the somite (Figs. 1A-C). Strong activation of somite myogenesis was also observed following RCAS-ΔNLef1-VP16 infection consistent with the documented effect of canonical Wnt signaling on myogenic commitment (Borello et al., 2006; Gros et al., 2009) . Interestingly, the increased expression of the myogenic markers, Pax-7 and Pax-3, suggests that Wnt/Lef1 may act early during myogenic commitment at least in somites. In the limb and branchial arch muscles, however, manipulation of Lef1 activity or application of the Wnt antagonist, Dkk1, showed that myogenic commitment/maintenance does not require the canonical Wnt signaling pathway (Fig. 4) . This is in keeping with observations reported in transgenic mice, where conditional activation or inactivation of β-catenin was used to demonstrate that early and late limb muscle progenitors have distinct requirements for β-catenin (Hutcheson et al., 2009) .
We also analysed the expression and function of a putative downstream target of canonical Wnt signaling, Pitx2, which in In the Pitx2a-En-infected limb, the Anc muscle is absent and the EDC and EMR muscles are decreased in size. In the Pitx2a-infected limb, the Anc, EIL, EDC and EMR muscles are increased in size. Anc, anconeus; EDC, extensor digitorum communis; EIL, extensor indicis longus; EMR, extensor metacarpi radialis; EMU, extensor metacarpi ulnaris; FDP, flexor digitorum profundus; PP, pronator profundus; PS, pronator superficialis.
epithelial cells can act in synergy with Lef1 to promote Lef1 transcription (Vadlamudi et al., 2005) . We have shown that Pitx2 is regulated by the canonical Wnt pathway in the epaxial somite and second branchial arch, but not in the first branchial arch (Figs. 2 and  4) . However, in all regions, misexpression of Pitx2 increases the number of myogenic cells (Figs. 2 and 5; Dong et al., 2006) .
We previously proposed that canonical Wnt signaling may regulate myogenic differentiation in the developing limb bud. Evidence to support this was the ability of the dominant-negative Lef1 construct to reduce myocyte number as assayed by the expression of MyHC chain when misexpressed in limb cultures (Anakwe et al., 2003) . Furthermore, the Wnt antagonist, Sfrp2, reduced myocyte number in vivo and in vitro (Anakwe et al. 2003) . Here, we show that canonical Wnt signaling does not regulate MyoD or Myf5 expression in developing limb buds, indicating that, in contrast to the epaxial musculature of somites, limb myogenesis is not initiated via the Wnt/β-catenin pathway. Therefore, the role of canonical Wnt signaling in the development of the embryonic limb musculature is presently unclear and may occur at later stages of differentiation after myogenic commitment. Alternatively, canonical Wnt signaling may regulate cell proliferation and/or survival.
Inhibition of Wnt signaling in the early cranial paraxial mesoderm results in the premature and ectopic activation of MyoD expression (Tzahor et al., 2003) . The Wnt inhibition studies reported here in which we show that the expression of MyoD, together with Myf5 and MyoR (Fig. 4) is not regulated by canonical Wnt signaling at first appear to be at odds with the previous study. There are two obvious explanations for this discrepancy. First, myogenic cells in the proximal versus distal first branchial arch have distinct molecular signatures reflecting their different origins; the cranial paraxial and lateral splanchnic mesoderm, respectively (Nathan et al., 2008) . These distinct regions may be differentially controlled by the canonical Wnt pathway: to date, it has been shown that the distal musculature is regulated by Wnt signaling at early stages (8-10) of development (Nathan et al., 2008) . The studies described here focus on the proximal region. Second, the experiments presented here were at a later stage of development (stage 20/21 versus stage 8/10). Regardless of the explanation for the differences, what the data does conclusively show is that once myogenic commitment is initiated within the proximal branchial arch, canonical Wnt signaling is not required to maintain myogenic differentiation.
The Pitx2 promoter contains Tcf/Lef binding sites and expression can be induced by LiCl, which activates the canonical Wnt signaling pathway (Vadlamudi et al., 2005) . Our analysis here shows that Pitx2 expression is differentially regulated by Wnt/Lef1 signaling in the different regions of the body: canonical Wnt signaling does control Pitx2 expression in the epaxial myotome (Figs. 2C and D) and in the second branchial arch mesoderm and ectoderm (Figs. 4W-Y) , but is not required for Pitx2 expression in the first branchial arch (Fig. 4W) . In the developing limb bud, we have found that RCAS-ΔNLef-VP16 at early stages led to upregulation of Pitx2 in infected forelimb buds (Figs. 4M and N) ; however, implanting Dkk1-inhibitor beads at HH stage 20/21 did not result in loss of Pitx2 expression (Fig. 4A ). This suggests that migratory muscle progenitors are sensitive to increased Wnt signaling, whereas differentiating myoblasts no longer require Wnt to maintain Pitx2 expression.
Targeted misexpression was used to examine the function of Pitx2 in somites and limb buds. This showed that Pitx2 is important for primary myogenesis, in particular in the epaxial somite. Both Lef1-VP16 and Pitx2 infection increased the number of myogenic cells (Figs. 1, 2, and 5) . The effects observed with Pitx2-En and Pitx2a are highly reminiscent of those seen following the manipulation of Wnt/ Lef1 signaling. We considered the following possibilities for how Lef1 and Pitx2 may regulate myogenic cell number. Pitx2 and Lef1 may increase the number of myogenic cells by (a) increasing commitment of premyogenic cells to the myogenic lineage, (b) promoting cell proliferation, and/or (c) decreasing apoptosis. There is no evidence of significant apoptosis within the developing dermomyotome and myotome, thus making the last scenario unlikely. However, the first scenario is consistent with our finding that targeted misexpression of activated or de-repressed Lef1 mutant proteins (ΔN-Lef1-VP16, ΔN-Lef1), i.e., activation of the canonical Wnt pathway, increased the number of cells expressing early myogenic markers (Figs. 1B and D; Supplemental Fig. 1B) . Counting the number of mitotic, phosphohistone H3-positive cells in the dermomyotome and myotome suggests that canonical Wnt signaling via Lef1 and Pitx2 also stimulates the proliferation of myogenic progenitor cells by 30% (Fig. 3) , which overall leads to a thickened myotome. A previous study showed that Wnt-3a regulates proliferation in HH10 somite explants. These authors also showed that ectopic expression of Wnt-3a in the neural tube in vivo results in enhanced proliferation of dorsal/ dermomyotomal cells and the subsequent expansion of the dermomyotome and myotome (Galli et al., 2004) . Our results are consistent with this and further demonstrate that Lef1 and Pitx2 are the effectors of Wnt signaling cues. Other recent studies have implicated roles for the notch signaling pathway and myostatin in controlling the balance between proliferation and differentiation of secondary myogenic progenitors that invade the primary myotome following the epithelial-to-mesenchymal transition of the central part of the dermomyotome. Mutations led to premature differentiation and thus the depletion of the progenitor pool, resulting in muscle hypotrophy (Manceau et al., 2008; Schuster-Gossler et al., 2007; Vasyutina et al., 2007) . Together with the data presented here, this indicates that different pathways are involved in regulating the number of primary and secondary myogenic progenitor cells.
The ability of Pitx2 to increase proliferation, in part by inducing the expression of cell cycle regulators such as cyclin D1 and D2, has previously been shown in cardiac cells and in the Sol8 and C2C12 myogenic cell lines (Kioussi et al., 2002; Martinez-Fernandez et al., 2006) . Pitx2 is also expressed in proliferating satellite cells, the progenitor cells of the adult musculature (data not shown). Therefore, a unifying theme of Pitx2 appears to be to increase proliferation.
Analysis of the Pitx2 null mouse embryo has shown that in the absence of Pitx2, differentiation of the first branchial arch musculature, but not the second branchial arch, is affected (Dong et al., 2006; Shih et al., 2007a) . This demonstrated that differential molecular programmes regulate myogenesis in the first and second branchial arch and is consistent with the identification of an enhancer that initiates Myf5 expression specifically in the second branchial arch (Summerbell et al. 2000) . The Dkk1 bead implants (Fig. 4) also seem to uncouple a role for Pitx2 and myogenic differentiation in the second branchial arch mesoderm.
Overall, this study provides insight into the molecular players downstream of Wnt signaling, which are involved in embryonic myogenesis, and uncovers some striking differences in different muscle groups.
